Covers pharmaceutical grade gelatin properties, Bloom and viscosity ranges, GMP production controls, USP/EP/JP/ChP compliance, BSE/TSE supply requirements, and common capsule, softgel, tablet coating, and binding applications.
Pharmaceutical grade gelatin is a high-purity protein material widely used in capsules, tablets, and other drug delivery systems. Unlike food or industrial gelatin, it must meet strict bioburden, heavy metal, and viscosity requirements to ensure patient safety and manufacturing consistency. This guide covers its core properties, applicable standards, production controls, and common use cases for pharmaceutical manufacturers and formulation teams.
Pharmaceutical grade gelatin is a denatured protein derived from collagen through controlled alkaline, acid, or enzymatic hydrolysis. Raw materials typically include bovine bone, bovine hide, and porcine skin sourced from BSE/TSE-controlled supply chains. The final product forms thermoreversible gels and films, making it suitable for hard capsules, softgels, tablet coatings, and binding applications.
Compared with industrial or food grades, pharmaceutical gelatin is produced under GMP conditions and tested for critical quality attributes such as gel strength, viscosity, pH, moisture, sulfite content, peroxide value, and microbial limits. These parameters directly influence capsule forming, sealing performance, dissolution behavior, and long-term stability.
The functional performance of pharmaceutical grade gelatin depends on several measurable properties that affect both processing and end-product quality:
| Property | Typical Parameter Range | Relevance to Pharmaceutical Use |
|---|---|---|
| Gel strength (Bloom) | 150–280 g | Determines capsule wall firmness, moldability, and mechanical stability |
| Viscosity | 2.5–4.5 mPa·s (6.67%, 60°C) | Affects dipping performance, film thickness, and softgel spread |
| pH | 4.0–6.5 | Influences compatibility with active ingredients and dissolution profile |
| Moisture content | 9.0–13.0% | Impacts brittleness, flexibility, and microbial stability |
| Heavy metals | ≤20 ppm | Required for compendial compliance and patient safety |
| Total aerobic count | ≤1000 CFU/g | Controls bioburden for oral dosage form manufacturing |
Type A gelatin, produced by acid processing, usually has a lower pH and higher isoelectric point, while Type B gelatin, produced by alkaline processing, tends to show higher viscosity and different gelling behavior. Formulators select the appropriate type and Bloom grade based on dosage form requirements, processing equipment, and fill characteristics.
Pharmaceutical grade gelatin must comply with major pharmacopeia monographs, including USP, EP, JP, and ChP. These standards define acceptable limits for identification, purity, microbial quality, residue levels, and functional performance. Manufacturers are also expected to maintain traceability throughout the supply chain, including raw material origin, rendering controls, and purification records.
For global markets, additional regulatory expectations include:
Because gelatin is a material of animal origin, regulatory reviews often focus heavily on source control, transmissible spongiform encephalopathy risk, and viral safety validation. These factors are especially important for products intended for regulated markets such as the EU, the United States, and Japan.
The production of pharmaceutical grade gelatin follows a tightly controlled sequence designed to remove impurities while preserving functional gelling properties. Although exact parameters vary by raw material and gelatin type, the core process generally includes:
Approved bovine or porcine raw materials are inspected, cleaned, and size-reduced before processing. Suppliers must provide traceability documentation and health status certification to support pharmaceutical use.
Collagen is treated with dilute acid or lime to break non-covalent crosslinks and prepare the material for controlled hydrolysis. This stage strongly influences final gelatin type, Bloom strength, and viscosity.
Gelatin is extracted in successive hot water steps at increasing temperatures. Earlier fractions typically yield higher gel strength, while later fractions may show lower Bloom and higher viscosity.
Crude gelatin extract undergoes filtration, ion exchange, decolorization, and concentration to reduce salts, color bodies, organic impurities, and microbial load.
The purified solution is sterilized by UHT or validated thermal treatment, then gelled, dried, and milled to the required particle size. Finished batches are tested against pharmacopeia and customer specifications before release.
Pharmaceutical grade gelatin is used across multiple dosage forms due to its film-forming ability, gel strength, and established regulatory acceptance.
Two-piece hard capsules remain one of the largest applications for pharmaceutical grade gelatin. The material provides consistent shell formation, reliable lock closure, and predictable disintegration in the gastrointestinal tract.
For oil-based fills, suspensions, and lipid formulations, gelatin softgels offer accurate dosing, good seal integrity, and improved swallowability. Gelatin viscosity and Bloom strength are critical for ribbon formation and rotary die processing.
Gelatin can act as a binder in wet granulation or as a component in film coating systems, helping to improve tablet strength, surface finish, and dust control during compression.
Additional applications include suppository bases, lozenges, hemostatic formulations, plasma expanders, and certain medical device matrices. These uses often require even tighter endotoxin, bioburden, or pyrogen controls.
When sourcing pharmaceutical grade gelatin, quality teams should evaluate more than certificate-of-analysis values. Consistent batch-to-batch performance depends on raw material control, process validation, and long-term supplier capability.
Key evaluation points include:
For capsule and softgel manufacturers, even minor viscosity or gel strength variation can lead to shell defects, filling problems, or dissolution failures. That is why pharmaceutical grade gelatin is typically qualified through pilot trials and ongoing supplier monitoring rather than specification review alone.
Pharmaceutical grade gelatin is a foundational excipient in oral dosage form manufacturing, combining proven functionality with broad regulatory acceptance. Its performance is determined by a combination of raw material origin, hydrolysis method, purification controls, and final testing against pharmacopeia standards. For pharmaceutical manufacturers, selecting a consistent, fully documented gelatin source is essential to maintaining dosage form quality, processing efficiency, and regulatory compliance.
Contact our technical experts for personalized assistance.